Beta Bionics, Inc. financial data

Symbol
BBNX on Nasdaq
Location
Irvine, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 28 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1152% %
Quick Ratio 81% %
Debt-to-equity 24% %
Return On Equity -47% %
Return On Assets -27% %
Operating Margin -77% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 44,024,631 shares
Common Stock, Shares, Outstanding 43,991,598 shares
Common Stock, Value, Issued $4,000 USD
Weighted Average Number of Shares Outstanding, Basic 43,634,006 shares 555%
Weighted Average Number of Shares Outstanding, Diluted 43,634,006 shares 555%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $88,570,000 USD 63%
Research and Development Expense $33,872,000 USD 59%
Selling and Marketing Expense $55,874,000 USD 66%
General and Administrative Expense $27,130,000 USD 55%
Operating Income (Loss) $68,594,000 USD -55%
Nonoperating Income (Expense) $9,248,000 USD 128%
Net Income (Loss) Attributable to Parent $77,842,000 USD -46%
Earnings Per Share, Basic -4 USD/shares 77%
Earnings Per Share, Diluted -4 USD/shares 77%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $38,485,000 USD 120%
Accounts Receivable, after Allowance for Credit Loss, Current $11,539,000 USD
Inventory, Net $20,373,000 USD
Other Assets, Current $265,000 USD
Assets, Current $270,026,000 USD
Property, Plant and Equipment, Net $7,385,000 USD
Operating Lease, Right-of-Use Asset $7,024,000 USD
Other Assets, Noncurrent $183,000 USD
Assets $330,046,000 USD
Accounts Payable, Current $4,461,000 USD
Employee-related Liabilities, Current $11,009,000 USD
Liabilities, Current $25,388,000 USD
Operating Lease, Liability, Noncurrent $5,707,000 USD
Other Liabilities, Noncurrent $1,205,000 USD
Liabilities $35,286,000 USD
Accumulated Other Comprehensive Income (Loss), Net of Tax $354,000 USD
Retained Earnings (Accumulated Deficit) $356,471,000 USD
Stockholders' Equity Attributable to Parent $294,760,000 USD
Liabilities and Equity $330,046,000 USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $19,975,000 USD -64%
Net Cash Provided by (Used in) Financing Activities $211,119,000 USD 3518550%
Net Cash Provided by (Used in) Investing Activities $179,122,000 USD -2443%
Common Stock, Shares Authorized 700,000,000 shares
Common Stock, Shares, Issued 43,991,598 shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $12,022,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $38,585,000 USD 119%
Operating Lease, Liability $7,687,000 USD
Depreciation $303,000 USD 5.6%
Payments to Acquire Property, Plant, and Equipment $333,000 USD -18%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $77,546,000 USD -45%
Lessee, Operating Lease, Liability, to be Paid $9,327,000 USD
Property, Plant and Equipment, Gross $13,673,000 USD
Operating Lease, Liability, Current $1,980,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,418,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $2,006,000 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,640,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,384,000 USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,092,000 USD
Operating Lease, Payments $400,000 USD 33%
Additional Paid in Capital $650,873,000 USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $13,633,000 USD 127%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%